NCT05979623View on ClinicalTrials.gov

Clinicopathological Characteristics and Prognosis Analysis of Stage IB Non-small Cell Lung Cancer

CompletedOBSERVATIONAL
Enrollment

971

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2022

Conditions
Stage IB Non-Small Cell Lung Carcinoma
Trial Locations (1)

200032

180 Fenglin Road, Shanghai

All Listed Sponsors
lead

Shanghai Zhongshan Hospital

OTHER

NCT05979623 - Clinicopathological Characteristics and Prognosis Analysis of Stage IB Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter